1. Wang MH, Zhao Y, Deng YZ, Xue FB, Xie HT, Yao C. Comparative study on policies, regulations and guiding principles for the application of real-world data/real-world evidence. Chin J Clin Pharmacol Therapeut (Chin) 2020;25:878–889.
2. U.S. Government. 21st Centruy Cures Act. (2016-12-13) Accessed October 1, 2021. Available at https://www.Congress.gov/114/plaws/publ255/PLAW-114publ255.pdf
3. National Medical Products Administration. Guiding principles for real-world evidence supporting drug development and review (testing version). Accessed October 1, 2021. Available at http://www.nmpa.gov.cn/WS04/CL2138/373175.html.
4. National Medical Products Administration. Special regulations on the registration and administration of traditional Chinese medicine (draft for public comment). Accessed September 6, 2021. Available at https://www.nmpa.gov.cn/xxgk/zhqyj/zhqyjyp/20200430154501315.html
5. Akobeng AK. Assessing the validity of clinical trials. J Pediatr Gastroenterol Nutr 2008;47:277–282.